EAACI logo EAACI logo
  • EAACI
    EAACI

    Learn about what we do and who we work with, our leadership, governance, and advocacy efforts.

    • About EAACI
    • Programmes & Awards
    • Membership
    • Leadership & Organisation
    • External Partners
    • Governance
    • Advocacy
  • Events
    Events

    Through a wide range of scientific events, EAACI provides a highly respected avenue for communication and knowledge-exchange. Find your next event.

    • Annual Congress
    • Focused Meetings
    • Master Classes
    • Allergy & Winter Schools
    • Other EAACI Events
    • International Events
  • Professionals
    Professionals

    Find out how to get involved. Become a member, join our numerous sections, interest groups, working groups and task forces and get your research rolling, or deepen your education by visiting our Knowledge Hub.

    • My EAACI
    • Knowledge Hub
    • Sections, IGs, WGs
    • Job center
  • Patients
    Patients

    Our community constantly works towards improving patient lives. Find resources and information dedicated to allergy and asthma patients and their families and loved ones in this section.

    • Patient Resources
    • Patient Organisations
    • Knowledge Hub
  • News
    News

    Stay up to date with what is happening within the EAACI Family and beyond in terms of research, event updates and more.

    • In the spotlight
    • Press
    • Press Regulations
Become a Member
myEAACI

Welcome

  • Log in
  • MyEAACI Portal
  • EAACI Journals
  • My Membership
  • CME Certificates
  • Home
  • Agenda
  • EAACI Congress 2025
  • Speakers
  • Martin Wagenmann

EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Martin Wagenmann

Germany

Martin Wagenmann

Sessions

Friday 13 Jun
14:03 - 14:15 Dupilumab Effectiveness Through Two Years in Patients with CRSwNP Treated in Real-World Practice: Results from the Global AROMA Registry
14:15 - 14:27 Improved Quality of Life, Early Symptom Control and Reduced Surgery with Mepolizumab in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Results from the SYNAPSE Study
Monday 16 Jun
10:52 - 10:59 Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Share this pen

Facebook
Twitter
LinkedIn
Email
https://main-eaaci.quanti.cz/agenda/eaaci-congress-2024/speakers/martin-wagenmann/
Link was copied!
×
  • EAACI
    • About EAACI
    • Programmes & Awards
    • Membership
    • Leadership & Organisation
    • External Partners
    • Governance
    • Advocacy
  • Events
    • Annual Congress
    • Focused Meetings
    • Master Classes
    • Allergy & Winter Schools
    • Other EAACI Events
    • International Events
  • Professionals
    • My EAACI
    • Knowledge Hub
    • Sections, IGs, WGs
    • Job center
  • Patients
    • Patient Resources
    • Patient Organisations
    • Knowledge Hub
  • News
    • In the spotlight
    • Press
    • Press Regulations
  • social media icon
  • social media icon
  • social media icon
  • social media icon
  • social media icon
Copyright © 2023 EAACI All rights reserved.
  • Contact
  • Privacy